You are here: Industry Insights > Co-Diagnostics

News List

Co-Diagnostics Completes EUA Submission for Extraction-Free Saliva COVID-19 Test americanpharmaceuticalreview
February 05, 2021
Co-Diagnostics has completed its submission to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) of its Logix Smart™ SARS-CoV-2 DS (Direct Saliva) test, a COVID-19 polymerase chain reaction (PCR) diagnostic designed ...
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test prnewswire
November 26, 2020
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received ...
Co-Diagnostics, Inc. Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test prnewswire
August 21, 2020
Co-Diagnostics, Inc. announced that the United States Patent and Trademark Office has granted increased patent protection for the Company's COVID-19 test kit and its other molecular diagnostic tests.
Co-Diagnostics Receives FDA Emergency Use Authorization for COVID-19 Test americanpharmaceuticalreview
April 09, 2020
Co-Diagnostics announced its Logix Smart™ Coronavirus COVID-19 Test has obtained Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA).
Co-Diagnostics gets CE mark for Zika, Dengue, Chikungunya diagnostic test biospectrumasia
March 12, 2019
Co-Diagnostics, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that its Logix Smart™ ZDC Test has obtained CE mark regulatory clearance to be sold as an in vitro diagnostic (“I